Source: Institutional Research Information System (IRIS)
Cinausero M.; Laprovitera N.; Maglio G.D.; Gerratana L.; Riefolo M.; Macerelli M.; Fiorentino M.; Porcellini E.; Buoro V.; Gelsomino F.; Squadrilli A.; Fasola G.; Negrini M.; Tiseo M.; Ferracin M.; Ardizzoni A., KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC, «THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY», 2019, 11, pp. 1 - 13 [Scientific article] Open Access
Ramassone A.; D'Argenio A.; Veronese A.; Basti A.; Soliman S.H.A.; Volinia S.; Bassi C.; Pagotto S.; Ferracin M.; Lupini L.; Saccenti E.; Balatti V.; Pepe F.; Rassenti L.Z.; Innocenti I.; Autore F.; Marzetti L.; Mariani-Costantini R.; Kipps T.J.; Negrini M.; Laurenti L.; Visone R., Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study, «JOURNAL OF HEMATOLOGY & ONCOLOGY», 2019, 12, pp. 1 - 5 [Scientific article] Open Access
Gulei D.; Raduly L.; Broseghini E.; Ferracin M.; Berindan-Neagoe I., The extensive role of miR-155 in malignant and non-malignant diseases, «MOLECULAR ASPECTS OF MEDICINE», 2019, 70, pp. 33 - 56 [Scientific article]
Bacci M.; Lorito N.; Ippolito L.; Ramazzotti M.; Luti S.; Romagnoli S.; Parri M.; Bianchini F.; Cappellesso F.; Virga F.; Gao Q.; Simoes B.M.; Marangoni E.; Martin L.-A.; Comito G.; Ferracin M.; Giannoni E.; Mazzone M.; Chiarugi P.; Morandi A., Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer, «CELL REPORTS», 2019, 28, pp. 104 - 118 [Scientific article] Open Access
Visone R.; Bacalini M.G.; Franco S.D.; Ferracin M.; Colorito M.L.; Pagotto S.; Laprovitera N.; Licastro D.; Marco M.D.; Scavo E.; Bassi C.; Saccenti E.; Nicotra A.; Grzes M.; Garagnani P.; Laurenzi V.D.; Valeri N.; Mariani-Costantini R.; Negrini M.; Stassi G.; Veronese A., DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells, «EPIGENOMICS», 2019, 11, pp. 587 - 604 [Scientific article] Open Access
Venturi G.; Gomes Ferreira I.; Pucci M.; Ferracin M.; Malagolini N.; Chiricolo M.; Dall'Olio F., Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types, «GLYCOBIOLOGY», 2019, 29, pp. 684 - 695 [Scientific article] Open Access
Gallerani G.; Fici P.; Coatti A.; Mariotti P.; Passeri F.; Battistelli L., Crowdfunding for cancer research: the TRACe campaign as an example, «THE LANCET ONCOLOGY», 2019, 20, pp. 622 - 624 [Scientific article]
Bandini E.; Rossi T.; Gallerani G.; Fabbri F., Adipocytes and micrornas crosstalk: A key tile in the mosaic of breast cancer microenvironment, «CANCERS», 2019, 11, pp. 1451 - 1451 [Scientific article] Open Access
Visioli A.; Giani F.; Trivieri N.; Pracella R.; Miccinilli E.; Cariglia M.G.; Palumbo O.; Arleo A.; Dezi F.; Copetti M.; Cajola L.; Restelli S.; Papa V.; Sciuto A.; Latiano T.P.; Carella M.; Amadori D.; Gallerani G.; Ricci R.; Alfieri S.; Pesole G.; Vescovi A.L.; Binda E., Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies, «EBIOMEDICINE», 2019, 44, pp. 346 - 360 [Scientific article] Open Access
Porcellini, Elisa; Laprovitera, Noemi; Riefolo, Mattia; Ravaioli, Matteo; Garajova, Ingrid; Ferracin, Manuela, Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications, «CANCER LETTERS», 2018, 419, pp. 84 - 95 [Scientific article]